These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6099489)

  • 1. Activity profiles of novel side-chain to side-chain cyclized opioid peptide analogs.
    Schiller PW; Nguyen TM
    Neuropeptides; 1984 Dec; 5(1-3):165-8. PubMed ID: 6099489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW; Nguyen TM; Lemieux C; Maziak LA
    J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cyclic opioid peptide analog showing high preference for mu-receptors.
    Schiller PW; Nguyen TM; Maziak L; Lemieux C
    Biochem Biophys Res Commun; 1985 Mar; 127(2):558-64. PubMed ID: 2983726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides.
    Schiller PW; Nguyen TM; DiMaio J; Lemieux C
    Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of cyclic beta-casomorphin-5 analogues.
    Schmidt R; Neubert K; Barth A; Liebmann C; Schnittler M; Chung NN; Schiller PW
    Peptides; 1991; 12(6):1175-80. PubMed ID: 1667685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
    Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the opioid activity of a number of enkephalin and dermorphin analogs].
    Chichenkov ON; Sumbatian NV; Riabtseva ON; Korshunova GA; Shorr VA
    Farmakol Toksikol; 1988; 51(5):17-20. PubMed ID: 2850219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
    J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogs.
    Vavrek RJ; Cui RL; York EJ; Stewart JM; Paterson S; Kosterlitz HW
    Life Sci; 1983; 33 Suppl 1():451-4. PubMed ID: 6319902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
    Mosberg HI; Heyl DL; Haaseth RC; Omnaas JR; Medzihradsky F; Smith CB
    Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
    Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
    Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side chain to side chain cyclization of an enkephalin analog results in loss of opioid receptor selectivity.
    Schiller PW; Maziak LA; Lemieux C; Nguyen TM
    Int J Pept Protein Res; 1986 Nov; 28(5):493-7. PubMed ID: 3028973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
    Edwards JV; Spatola AF; Lemieux C; Schiller PW
    Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of the preferential involvement of mu receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptors.
    Gacel G; Fournié-Zaluski MC; Fellion E; Roques BP
    J Med Chem; 1981 Oct; 24(10):1119-24. PubMed ID: 6276540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.
    Mosberg HI; Omnaas JR; Medzihradsky F; Smith CB
    Life Sci; 1988; 43(12):1013-20. PubMed ID: 2845204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.